• EdU Imaging Kits (HF594): Evidence and Limits

  2026-10-05

  EdU Imaging Kits (HF594) use 5-ethynyl-2’-deoxyuridine to identify DNA synthesis during S phase. The approach is relevant to proliferation studies, but the supplied PDAC study supports biological context rather than direct validation of this specific kit.

• PD 0332991: Five Questions on Evidence

  2026-10-05

  A source-grounded overview of PD 0332991 (Palbociclib HCl), covering CDK4/6 biology, Rb signaling, senescence evidence, interpretation, and limits of translating cell-model findings.

• PXR Activation, Liver Regeneration, and CYP Activity

  2026-10-04

  Bi et al. show that pregnane X receptor activation in rats links liver enlargement and regeneration with increased functional activity of CYP3A1/2 and CYP2C6/11. The study is important because it evaluates metabolic performance alongside liver growth, while also highlighting the limits of translating rodent PXR findings to human drug disposition.

• E-64d: Research Context and Evidence Limits

  2026-10-03

  E-64d is a membrane-permeable cysteine protease inhibitor used conceptually to investigate calpain- and cathepsin-linked biology. This overview compares supplier-described properties with the peer-reviewed lysoptosis study, emphasizing what the evidence supports, where interpretation remains uncertain, and why E-64d should not be treated as a selective stand-alone proof of any cell-death pathway.

• UBR1 and UBR2 in Mammalian ER Stress Sensing

  2026-10-02

  The reference study identifies the N-recognin E3 ligases UBR1 and UBR2 as stress-responsive regulators of mammalian protein quality control. Its experiments connect N-degron pathway activity with ER stress adaptation and show that loss of these factors increases susceptibility to stress-induced apoptosis, while also defining important mechanistic gaps for future research.

• DHEA at the Gut–Ovary–Brain Interface

  2026-10-01

  Dehydroepiandrosterone (DHEA) is more than a steroidal reagent: it is both a mechanistic driver in PCOS models and a probe of ovarian, neuronal, and apoptotic biology. New evidence connecting polystyrene microplastics, gut microbiota, vitamin B6 depletion, and ovarian inflammation makes DHEA especially valuable for designing translational experiments that separate endocrine susceptibility from environmental toxicity.

• Inducing Right Ventricular-Like Cardiomyocytes

  2026-10-01

  Saito and colleagues developed a strategy to bias human pluripotent stem cell cardiac differentiation toward right ventricular-like cardiomyocytes by modifying mesoderm formation in a GiWi protocol. The resulting cells showed second heart field-associated molecular features and functional differences from predominantly left ventricular-like cardiomyocytes, providing a more relevant platform for chamber-specific disease modeling.

• Protease and Phosphatase Inhibitor Cocktail for HMGB1

  2026-09-30

  Discover how a Protease and Phosphatase Inhibitor Cocktail preserves HMGB1 abundance and phosphorylation-sensitive signaling in lactate–sepsis studies. This article translates mechanistic findings into practical, EDTA-free protein extraction and assay decisions.

• MLKL Polymerization and Lysosomal Permeabilization

  2026-09-30

  The reference study identifies MLKL polymerization-induced lysosomal membrane permeabilization as a central execution step in necroptosis. Its imaging, perturbation, and cathepsin B experiments connect activated MLKL at lysosomal membranes to organelle disruption, cytosolic protease release, and subsequent cell death.

• BHQ: From Calcium Control to HSC Mobilization

  2026-09-29

  A translational perspective on 2,5-di-tert-butylbenzene-1,4-diol (BHQ) as a SERCA-centered probe linking calcium homeostasis, ER stress, vascular physiology, and hematopoietic stem cell mobilization.

• NIH/3T3 Cells: Recovery, Culture, and QC

  2026-09-29

  NIH/3T3 Cells (BC1017) provide a cryopreserved, adherent mouse fibroblast starting material for controlled recovery, expansion, transfection, viral proliferation studies, and oncogene research. This guide describes practical handling and quality checks, while clarifying that the dossier does not establish virus-specific permissiveness, quantitative assay performance, clinical utility, or diagnostic use.

• E-64d: Reading Protease-Driven Cell Death

  2026-09-28

  E-64d is a membrane-permeable cysteine protease inhibitor for probing calpain- and cathepsin-dependent biology. This article connects its covalent pharmacology with time-resolved death-rate analysis, offering a more rigorous framework for apoptosis, platelet, seizure-model, and cancer research assays.

• EZ Cap™ Mouse IL-7 mRNA: Evidence and Use

  2026-09-28

  EZ Cap™ Mouse IL-7 mRNA (m1Ψ, HA tag) is the product name listed by APExBIO for R1054; the supplied product dossier does not specify sequence, formulation, or experimental conditions. The cited APOL1 study concerns a separate protein and does not establish the product’s performance or mechanism.

• Protease Inhibitor Cocktail: K1008 Guide

  2026-09-27

  The Protease Inhibitor Cocktail (EDTA-Free, 200X in DMSO) is a broad-spectrum protein extraction protease inhibitor for limiting proteolysis during sample preparation. K1008 is supplied as a 200X solution, is EDTA-free, and supports workflows including Western blotting and co-immunoprecipitation when diluted and used as directed.

• Puromycin Aminonucleoside for Podocyte Injury Studies

  2026-09-26

  Build a controlled podocyte injury model with practical guidance for dose finding, proteinuria endpoints, and renal tissue assessment. This guide also explains where emerging proteomic tools can complement—not replace—direct measures of glomerular injury.

547 records 2/37 page Previous Next 12345 下5页 Last page